Jeffrey D. Kahl
Hoofd Techniek/Wetenschap/O&O bij Azaya Therapeutics, Inc.
Profiel
Jeffrey D.
Kahl is Senior Director is Research and Development for Azaya Therapeutics, Inc. Prior to joining Azaya, he was Senior Director of Research and Development for BioNumerik Pharmaceuticals.
Dr. Kahl received a PhD from Texas Tech University.
Actieve functies van Jeffrey D. Kahl
Bedrijven | Functie | Begin |
---|---|---|
Azaya Therapeutics, Inc.
Azaya Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Azaya Therapeutics, Inc. develops pharmaceutical products and systems. The firm offers contract development and manufacturing services, such as chemical testing, liposomal manufacturing services to speed drug development and regulatory progress for pharmaceutical, medical device developers and meet customers’ academic or commercial needs. The company was founded by John C. Kerr in 2003 and is headquartered in San Antonio, TX. | Hoofd Techniek/Wetenschap/O&O | - |
Eerdere bekende functies van Jeffrey D. Kahl
Bedrijven | Functie | Einde |
---|---|---|
BioNumerik Pharmaceuticals, Inc.
BioNumerik Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology BioNumerik Pharmaceuticals, Inc. discovers and develops new medicines for cancer treatment. The firm's products include Tavocept which has the potential to substantially increase patient survival in the most common type of lung cancer and possibly many other forms of cancer, and Karenitecin which is an investigational new anti-tumor drug in the camptothecin class of chemotherapy drugs. The company was founded by Frederick H. Hausheer on December 15, 1992 and is headquartered in San Antonio, TX. | Hoofd Techniek/Wetenschap/O&O | - |
Opleiding van Jeffrey D. Kahl
Texas Tech University | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 2 |
---|---|
Azaya Therapeutics, Inc.
Azaya Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Azaya Therapeutics, Inc. develops pharmaceutical products and systems. The firm offers contract development and manufacturing services, such as chemical testing, liposomal manufacturing services to speed drug development and regulatory progress for pharmaceutical, medical device developers and meet customers’ academic or commercial needs. The company was founded by John C. Kerr in 2003 and is headquartered in San Antonio, TX. | Health Technology |
BioNumerik Pharmaceuticals, Inc.
BioNumerik Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology BioNumerik Pharmaceuticals, Inc. discovers and develops new medicines for cancer treatment. The firm's products include Tavocept which has the potential to substantially increase patient survival in the most common type of lung cancer and possibly many other forms of cancer, and Karenitecin which is an investigational new anti-tumor drug in the camptothecin class of chemotherapy drugs. The company was founded by Frederick H. Hausheer on December 15, 1992 and is headquartered in San Antonio, TX. | Health Technology |